Bierrenbach Ana Luiza, Oliveira Claudia Di Lorenzo, Quintino Nayara Dornela, Baldoni Nayara Ragi, Moreira Carlos Henrique Valente, Ferreira Ariela Mota, Silva Lea Campos de Oliveira da, Oikawa Márcio, Nunes Maria do Carmo Pereira, Cardoso Clareci Silva, Haikal Desirée Sant'Ana, Ghilardi Fabio de Rose, Vieira Thallyta Maria, Ribeiro Antonio Luiz Pinho, Sabino Ester Cerdeira
Hospital Sírio-Libanês, São Paulo, São Paulo, Brazil.
Universidade Federal de São João del-Rei, Divinópolis, Minas Gerais, Brazil.
Rev Inst Med Trop Sao Paulo. 2025 Feb 7;67:e10. doi: 10.1590/S1678-9946202567010. eCollection 2025.
Chagas disease (ChD) remains a significant public health concern in the Americas, with challenges to accurately assessing its mortality burden due to under-reporting and misclassification. This study aimed to analyze mortality patterns of two cohorts of individuals with ChD-one comprising asymptomatic individuals with positive serology (REDS) and another with patients showing Chagas cardiomyopathy (SaMi-Trop)-to propose a method for estimating the potential under-registration of Chagas-related deaths and to find the factors influencing the identification of ChD as the underlying cause of death. We carried out a retrospective analysis of mortality data from these cohorts together with data on the Brazilian Mortality Information System. Causes of death were classified according to ICD-10 codes, and an expert review was used to find possible Chagas-related deaths. Logistic regression was used to explore predictors of ChD identification considering demographic and clinical variables. Of 2,488 patients, 381 died, 28.9% attributed to ChD, predominantly chronic ChD with cardiac involvement (B57.2). Using our method, we estimated a 53.8% potential under-registration rate for possible Chagas deaths. Males were negatively associated with Chagas disease identification, with an odds ratio of 0.52 (95%CI 0.24-1.1). No other significant associations were found, and the overall significance of the model was low. Our findings provide a potential measurement of under-registration, indicating that it may be substantial. These results underscore the need for improved identification and accurate reporting on death certificates. Strengthening the quality of mortality data is essential to understand Chagas-related mortality and guide public health strategies to reduce its impact.
恰加斯病(ChD)在美洲仍然是一个重大的公共卫生问题,由于报告不足和错误分类,准确评估其死亡负担面临挑战。本研究旨在分析两组恰加斯病患者的死亡模式,一组包括血清学阳性的无症状个体(REDS),另一组为患有恰加斯心肌病的患者(SaMi-Trop),以提出一种估计恰加斯病相关死亡潜在登记不足的方法,并找出影响将恰加斯病确定为根本死因的因素。我们对这些队列的死亡率数据以及巴西死亡信息系统的数据进行了回顾性分析。根据国际疾病分类第十版(ICD-10)编码对死因进行分类,并通过专家审查来找出可能与恰加斯病相关的死亡。使用逻辑回归来探索考虑人口统计学和临床变量的恰加斯病确定的预测因素。在2488名患者中,381人死亡,28.9%归因于恰加斯病,主要是伴有心脏受累的慢性恰加斯病(B57.2)。使用我们的方法,我们估计可能的恰加斯病死亡的潜在登记不足率为53.8%。男性与恰加斯病确定呈负相关,比值比为0.52(95%置信区间0.24 - 1.1)。未发现其他显著关联,且模型的总体显著性较低。我们的研究结果提供了一种潜在的登记不足测量方法,表明其可能相当大。这些结果强调了改进死亡证明上的识别和准确报告的必要性。加强死亡率数据的质量对于了解恰加斯病相关死亡率和指导公共卫生策略以减少其影响至关重要。